Učitavanje...
Naltrexone HCI/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives
Naltrexone, an opiate antagonist, and bupropion, a noradrenergic/dopaminergic antidepressant, have many effects on the reward systems of the brain. These medications impact eating behavior, presumably via their impact on food reward. However, only bupropion induces weight loss in obese individuals,...
Spremljeno u:
| Izdano u: | Patient Prefer Adherence |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4862388/ https://ncbi.nlm.nih.gov/pubmed/27217728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S84778 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|